TY  - GEN
N2  - The goal of this dissertation is to improve understanding and treatment for the chorioretinopathy seen in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) patients by examining the molecular mechanisms and testing potential treatments for LCHADD chorioretinopathy using a novel LCHADD mouse model. 
DO  - 10.6083/bpxhc43378
DO  - doi
AB  - The goal of this dissertation is to improve understanding and treatment for the chorioretinopathy seen in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) patients by examining the molecular mechanisms and testing potential treatments for LCHADD chorioretinopathy using a novel LCHADD mouse model. 
AD  - Oregon Health and Science University
T1  - Studying LCHADD chorioretinopathy using a novel LCHADD mouse model
ED  - Gillingham, Melanie
ED  - PI
DA  - 2024-06-13
AU  - Babcock, Shannon
L1  - https://digitalcollections.ohsu.edu/record/43378/files/Babcock.Shannon.2024.pdf
PB  - Oregon Health and Science University
LA  - eng
PY  - 2024-06-13
ID  - 43378
L4  - https://digitalcollections.ohsu.edu/record/43378/files/Babcock.Shannon.2024.pdf
KW  - Mitochondrial Trifunctional Protein
KW  - Genetic Therapy
KW  - Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase
KW  - Retinal Pigment Epithelium
KW  - LCHADD
KW  - chorioretinopathy
KW  - gene addition
KW  - fatty acid oxidation
KW  - RPE
TI  - Studying LCHADD chorioretinopathy using a novel LCHADD mouse model
Y1  - 2024-06-13
L2  - https://digitalcollections.ohsu.edu/record/43378/files/Babcock.Shannon.2024.pdf
LK  - https://digitalcollections.ohsu.edu/record/43378/files/Babcock.Shannon.2024.pdf
UR  - https://digitalcollections.ohsu.edu/record/43378/files/Babcock.Shannon.2024.pdf
ER  -